We've updated our Privacy Policy to make it clearer how we use your personal data.
We use cookies to provide you with a better experience, read our Cookie Policy

EP35879
Abstract: CD Genomics is an innovative sequencing and genotyping company. Our Disease Panel platform provides a series of proprietary, ultra-high multiplexed NGS target enrichment technology that integrates the company’s advanced panel design. The cancer panels are designed to address the practical needs of cancer-related studies. These panels are featured an innovative background cleaning technique that allows plenty of amplicons to be multiplexed in a single reaction pool, allowing a large number of cancer-related genes to be detected in a single assay. They can be designed as ready-to-use panels or as customized assays. Summary: The cancer panels are designed to address the practical needs of cancer-related studies. These panels are featured an innovative background cleaning technique that allows plenty of amplicons to be multiplexed in a single reaction pool, allowing a large number of cancer-related genes to be detected in a single assay. They can be designed as ready-to-use panels or as customized assays. References: https://www.cd-genomics.com/diseasepanel
Ask the author a question about this poster.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Related Posters
Surfarray Cell Microarray Technology_Creative Biolabs
Candy Swift
Build A Gene Mutation Panel with Non-NGS Technologies
CD Genomics
CD ssDNA-seq Lib Prep Kit for Illumina
CD Genomics
MICROBIOME STUDIES: 16S/18S/ITS Amplicon Sequencing or Metagenomics
CD Genomics
How to identify microorganisms quickly and accurately
CD Genomics